Contraceptives Drugs And Devices Market

Contraceptives Drugs And Devices Market - Insights,
Opportunity Analysis, and Industry Forecast till
2024
Contraceptive drugs and devices that aid to control birth rate and unintended pregnancies are
subject to unique regulatory challenges across different countries. For instance, contraceptive
drugs and devices face reimbursement challenges in the U.S., while contraceptive pills face
advertising restrictions in India. Owing to this, contraceptives preference greatly various across
countries. Statistics revealed by the United Nations in 2015, highlight this trends, with a
particular contraceptive accounting for over 50% share across 45 countries considered in the
study. Sterilization is a dominant contraceptive method in regions such as Asia, North America,
and Latin America as per the study. Intra-uterine devices (IUDs), vaginal rings, injectables,
implants, combined oral contraceptives, and patches are some of the more advanced
contraceptive methods available in the market. Introduction of new male contraceptive products
with high success rate are projected to shape the course of growth of the market in the near
future.
Download PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/365
The global contraceptive drugs and devices market was valued at US$ 18,273.2 million in 2015
and is expected to expand at a CAGR of 7.8% during the forecast period (2016 – 2024).
Market Dynamics
Use of contraceptives is low in emerging economies especially in Africa, according to report
‘Trends in Contraceptive Use Worldwide 2015’, of the United Nations in 2015. Moreover, WHO
estimates that around 225 million women in as of 2015, emerging economies who would like to
delay their pregnancy are not using any contraception method. The impact of this is realized
through the number of abortions carried out each year, with around 21.6 million unsafe
abortions reported annually. Around 85% of these are reported in emerging economies in Africa
and Asia, as per estimates of WHO (2016). Increasing awareness among the population through
government initiatives and increasing accessibility to various contraceptive devices and drugs are
expected to propel growth of contraceptive drugs and devices market in the near future.
Report includes chapters which deeply display the following deliverable about industry :
• Contraceptives Drugs And Devices Market Research Objective and Assumption
• Contraceptives Drugs And Devices Market Purview - Report Description, Executive Summary,
and Coherent Opportunity Map (COM)
• Contraceptives Drugs And Devices Market Dynamics, Regulations, and Trends Analysis Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Contraceptives Drugs And Devices Market, By Regions
• Contraceptives Drugs And Devices Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Contraceptives Drugs And Devices Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Contraceptives Drugs And Devices Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Contraceptives Drugs And Devices Market Forecast including Production, Consumption, Import
and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Market Taxonomy
This report segments the global contraceptives drugs and devices market on the basis of product
type and geography. On the basis of product type, the global contraceptives market is
segmented into drug and devices. Drugs are further sub-segmented into oral pills, injectables,
and topical contraceptives. The contraceptive devices segment is further sub-segmented into
male contraceptives devices and female contraceptives devices. Mentioned below is the detailed
segmentation. For comprehensive understanding of market dynamics, the global contraceptives
drugs and devices market is analyzed across key geographies namely North America, Europe,
Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis
of market findings across major countries in these regions for a macro-level understanding of
the market.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/365
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd.,
Church & Dwight Co. Inc., Reckitt Benckiser Plc, Pfizer, Inc., Bayer AG, Mayer Laboratories,
Inc., The Female Health Company, Cooper Surgical, Inc., Allergan plc, Cipla Limited, and
Merck & Co. Inc.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Contraceptives are birth spacing products that aid in avoiding unwanted/ unplanned pregnancy.